Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer

Aichi Cancer Center Hospital, Nagoya

Nagoya City University Hospital, Nagoya

Shikoku Cancer Center, Matsuyama

Kitakyushu Municipal Medical Center, Kitakyushu

Gunma Cancer Center, Ōta

Hokkaido Cancer Center, Sapporo

Hokkaido University Hospital, Sapporo

The Hospital of Hyogo College of Medicine, Nishinomiya

Tsukuba University Hospital, Tsukuba

Tokai University Hospital, Isehara

Kanagawa Cancer Center, Yokohama

Nahanishi Clinic, Naha

Kindai University Hospital, Sayama

Osaka University Hospital, Suita

Saitama Medical University International Medical Center, Hidaka

Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Bunkyo

National Cancer Center Hospital, Chūō

The Cancer Institute Hospital of JFCR, Koto

Toranomon Hospital, Minato

Showa University Hospital, Shinagawa

Chiba Cancer Center, Chiba

Kyushu Cancer Center, Fukuoka

Sagara Hospital, Kagoshima

Kumamoto University Hospital, Kumamoto

Kyoto University Hospital, Kyoto

Niigata Cancer Center Hospital, Niigata

Okayama University Hospital, Okayama

Osaka National Hospital, Osaka